Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AZN | AMGN | GILD | VRTX |
| Company | Alnylam Pharmaceuticals | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 280.11 | 177.67 | 344.38 | 125.85 | 462.17 |
| High | 282.98 | 177.80 | 345.00 | 126.39 | 464.98 |
| Low | 273.11 | 173.66 | 334.20 | 122.43 | 450.44 |
| Latest | 276.51 | 175.03 | 334.97 | 122.80 | 452.69 |
| Change | -6.21 | -2.86 | -6.69 | -2.65 | -6.30 |
| % Change | -2.20% | -1.61% | -1.96% | -2.11% | -1.37% |
| Volume | 753,157 | 1,055,163 | 2,228,702 | 3,597,603 | 848,379 |
| 20-Day Average Volume | 1,095,355 | 1,974,531 | 2,734,025 | 8,247,171 | 1,285,141 |
| Previous Close | 282.72 | 177.89 | 341.66 | 125.45 | 458.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 292.99 | 181.78 | 341.27 | 128.77 | 442.33 |
| 20-Day Raw Stochastic | 10.32% | 7.39% | 35.99% | 9.55% | 73.28% |
| 20-Day Relative Strength | 40.05 | 40.57 | 46.34 | 39.40 | 54.80 |
| Weighted Alpha | -23.80 | +15.36 | +12.37 | +6.09 | +5.12 |
| Today's Opinion | 100% Sell | 72% Sell | 8% Sell | 72% Sell | 40% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 24% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 24% Sell | 24% Sell | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.29% since 06/11/26 | -3.99% since 06/11/26 | -5.29% since 06/11/26 | -2.36% since 06/11/26 | +1.68% since 06/11/26 |
| Low | 273.11 on 06/18/26 | 173.70 on 06/18/26 | 334.20 on 06/18/26 | 122.43 on 06/18/26 | 439.50 on 06/15/26 |
| High | 291.28 on 06/12/26 | 182.70 on 06/12/26 | 358.30 on 06/15/26 | 128.20 on 06/17/26 | 464.39 on 06/18/26 |
| 1-Month | |||||
| %Chg | -3.25% since 05/18/26 | -4.84% since 05/18/26 | +3.37% since 05/18/26 | -5.22% since 05/18/26 | +3.65% since 05/18/26 |
| Low | 273.11 on 06/18/26 | 173.70 on 06/18/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 310.53 on 06/04/26 | 191.50 on 05/21/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 464.39 on 06/18/26 |
| 3-Month | |||||
| %Chg | -12.02% since 03/18/26 | -7.12% since 03/18/26 | -4.60% since 03/18/26 | -13.02% since 03/18/26 | +0.21% since 03/18/26 |
| Low | 273.11 on 06/18/26 | 173.70 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 343.36 on 04/14/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 464.39 on 06/18/26 |
| 6-Month | |||||
| %Chg | -30.06% since 12/18/25 | -3.43% since 12/18/25 | +3.36% since 12/18/25 | +1.18% since 12/18/25 | +1.15% since 12/18/25 |
| Low | 273.11 on 06/18/26 | 173.70 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 427.05 on 01/07/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 37,746,796 | 275,891,008 | 184,396,640 | 155,754,944 | 116,493,952 |
| Shares Outstanding, K | 133,513 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 3,713,940,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | 313,750,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 1,167,180,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | 205,990,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 0.29 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 04/30/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 07/30/26 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 77.23 | 19.30 | 15.74 | 15.20 | 26.94 |